000 -LEADER |
fixed length control field |
00807nam a22002417a 4500 |
001 - CONTROL NUMBER |
control field |
6076 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
BD-DhUAP |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20201202105434.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
201202s1996 enka b 001 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0748404368 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
PPiD |
Transcribing agency |
PPiD |
Modifying agency |
BD-DhUAP |
Language of cataloging |
Eng |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Edition number |
23 |
Classification number |
615.19072 ARM |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Armstrong, N. A. |
245 10 - TITLE STATEMENT |
Title |
Pharmaceutical experimental design and interpretation / |
Statement of responsibility, etc. |
N. Anthony Armstrong and Kenneth C. James. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
London : |
Name of publisher, distributor, etc. |
Taylor & Francis, |
Date of publication, distribution, etc. |
c1996. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
ix, 274 pages : |
Other physical details |
illustrations ; |
Dimensions |
26 cm. |
490 ## - SERIES STATEMENT |
Series statement |
Taylor & Francis series in pharmaceutical sciences. |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drugs |
General subdivision |
Research |
-- |
Methodology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Experimental design. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
James, Kenneth C. |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Koha item type |
Book |